Private Equity

PE Hub Wire

SVB Leerink's rapid expansion, UBS expects robust quarters ahead, Investcorp, Trilantic acquire RoadSafe

SVB Leerink goes on a hiring spree.

2 min read · 13 April 2021

Digging into KKR's $1.2b-plus deal for Lightyear's Therapy Brands, Another big LBO opportunity emerges in Medline Industries

Behind KKR's $1.25 billion Therapy Brands' buyout and Medline Industries is exploring a sale that could value it as much as $30 billion.

2 min read · 12 April 2021

Waud and ex-CenseoHealth execs join hands to launch new healthcare platform, SEC official gives warning to SPAC liabilities and risks

Waud's newest healthcare initiative and the SEC issues a warning on the SPACs' surge

2 min read · 09 April 2021

GHO Capital is buying NaviMed’s Velocity Clinical Research, Clearlake creates series of single-asset pools to extend holds

GHO Capital is buying Velocity Clinical Research and Clearlake extends holds with fund series.

3 min read · 08 April 2021

Avista's UBC prepares for sale, WindRose recaps Veristat, Toshiba confirms CVC's buyout proposal

Avista-backed United BioSource preps for sale and WindRose recaps Veristat.

2 min read · 07 April 2021

Silversmith-backed Absorb up for sale, Oval Partners offers unique deal structure to entice MSPs

Silversmith-backed Absorb Software goes on the block.

2 min read · 06 April 2021

Bain, J.H. Whitney-backed Aveanna files for IPO, Altaris-backed Senior Helpers commands around $180m in sale

Bain and J.H. Whitney-backed Aveanna files to go public.

2 min read · 05 April 2021

Atlantic Streets' Lab Logistics preps for sale, Cambridge Associates' Andrea Auerbach on how and why GPs are holding assets longer

Atlantic Street Capital’s Lab Logistics gets ready to go on the block.

2 min read · 02 April 2021

Deal of the Year: Thoma Bravo with Ellie Mae, WCAS-backed SpringStone seeks $1bn-plus in sale

Thoma Bravo’s sale of Ellie Mae is Deal of the Year and Welsh, Carson, Anderson & Stowe is exploring a sale of SpringStone.

3 min read · 01 April 2021

THL investment values Bazaarvoice at $1.5b-plus, Ares gains secondaries business through $1b Landmark acquisition, Avista sees opportunity to simplify early-stage drug-development

THL's investment in Bazaarvoice puts company at an over $1.5 billion valuation and Ares agrees to buy secondaries shop Landmark Partners.

2 min read · 31 March 2021

Showing 2,441 to 2,450 of 2,802 results
1…244246…281